Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • Read the submission guidelines prior to submission.
  • Submissions must follow the journal's manuscript formatting.
  • Published articles will include a CC BY-NC license. Read more about the license.
  • You must be the author, or the authorized agent of the author(s) and copyright holder. If different from the author(s):
    the author(s) must have approved the work for publication; the author(s) must have agreed to submit the article to the Journal; the author(s) must accept full responsibility for the content of the Article;
  • the Article must be the Author(s) original work and must not contain any libelous or unlawful statements or infringe on the rights or privacy of others or contain material or instructions that might cause harm or injury
  • the Article must not have been previously published, is not pending review elsewhere, and will not be submitted for review elsewhere pending the completion of the editorial decision process at the Journal.

Author Guidelines

Formatting Requirements

The cover page of a manuscript should include the title, all authors and institutions, and keywords, followed by a structured abstract.  

Structured abstracts are also submitted in the Abstract field during submission, and should use the following format: 

Abstract: Must include abstract. The abstract should be a concise description of the article. 
Type: Must select from the following: Commentary; Letter; Clinical Experience; Idea Paper; Original Research; Student Project; Book; Book Review; Case Study; Note; Review
Acknowledgements: Include only if applicable. 
Funding: Include only if applicable.
Conflicts of Interest: Must declare any conflicts of interest. If there are none to declare, please affirm use the following: We declare no conflicts of interest or financial interests that the authors or members of their immediate families have in any product or service discussed in the manuscript, including grants (pending or received), employment, gifts, stock holdings or options, honoraria, consultancies, expert testimony, patents and royalties.
Treatment of Human Subjects:  If you gathered data from or about humans, please indicate whether your paper received appropriate ethical review and approval. Select from: IRB review/approval required and obtained; IRB exemption granted; IRB determined project was non-HSR; none.
Link to streaming media: If you have streaming media associated with your submission, include the URL here. Video files (MP4, WAV, etc) can be uploaded with submission.

There are no page limits for manuscripts. For ease in communicating, the manuscript should include page numbers. Tables and Figures should be included in the manuscript document. If this is problematic, they may be submitted as separate files. It is preferred that references be identified by number and listed in numerical order using a standard style (e.g. AMA). Upon receipt, the editorial team will coordinate peer review using national and international experts. Feedback regarding the status of the manuscript will be given within 45 days of manuscript submission.

As an open access, web-based journal we encourage authors to be innovative and creative in disseminating their work. We gladly accept manuscripts that include web links, appendices, novel methods, and creative supporting materials.

Submission Agreement

Anyone may submit an original article to be considered for publication in INNOVATIONS in pharmacy provided he or she owns the copyright to the work being submitted or is authorized by the copyright owner or owners to submit the article. Authors are the initial owners of the copyrights to their works (an exception in the non-academic world to this might exist if the authors have, as a condition of employment, agreed to transfer copyright to their employer).

Submitted articles cannot have been previously published, nor be forthcoming in an archival journal or book (print or electronic). Please note: "publication" in a working-paper series does not constitute prior publication. In addition, by submitting material to INNOVATIONS in pharmacy, the author is stipulating that the material is not currently under review at another journal (electronic or print) and that he or she will not submit the material to another journal (electronic or print) until the completion of the editorial decision process at INNOVATIONS in pharmacy. If you have concerns about the submission terms for INNOVATIONS in pharmacy, please email the editors at iip@umn.edu.

Authorship confers credit and implies responsibility and accountability. INNOVATIONS conforms to the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals of the ICJME. To that end, authorship is based on four criteria: 1) substantial contributions to the conception or design of the work or the acquisition, analysis, or interpretation of data for the work; AND 2) drafting the work or revising it critically for important intellectual content; AND 3) final approval of the version to be published; AND 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriate investigated and resolved. All those designated as authors should meet all four criteria, and all who meet the criteria should be designated as authors. Those who do not meet all four criteria should be acknowledged.

By submitting you agree and consent to the Submission Agreement and the Journal policies.

Copyright Notice

Copyright of content published in INNOVATIONS in pharmacy belongs to the author(s).

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.